Search results
Results from the WOW.Com Content Network
While Greater Boston area biotechnology companies began announcing layoffs of 30 to 60% of company workforces (with some firms shutting down altogether) as the 2022 stock market decline began, [20] [21] the Greater Boston biotechnology industry workforce continued to grow from approximately 84,000 in 2020 to 114,000 in 2022. [22]
BeiGene was founded in late 2010 by John V. Oyler, [11] an American entrepreneur who serves as the company's chief executive officer and chairman, [30] alongside Xiaodong Wang, a Chinese American biochemist. Oyler and Wang envisioned a global multinational biopharmaceutical company focusing on cancer treatment. [11]
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Jointown brand face mask was the best-selling item on Amazon in the US for several consecutive months. The company became the 3rd largest medical distributor in China and ranked 93rd on Fortune 500 China. [8] In 2022, Jointown reached an annual revenue of CN¥140.4 billion [9] (US$19.8 billion [10]).
Three top Chinese pharmaceutical companies, which are backed by top global banks, are using endangered animal parts in their medicines, according to an investigation by an environmental protection ...
In January 2020, the company acquired Achillion Pharmaceuticals for $930 million, boosting its immune system disease pipeline. [ 39 ] [ 40 ] [ 41 ] In July 2020, Alexion acquired Portola Pharmaceuticals , diversifying its hematology, neurology, and critical care commercial portfolio with Portola's Factor Xa inhibitor reversal agent.
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, [2] with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, [3] and in New York, at The Cure by Deerfield. The company combines genomics, big data analysis, and deep learning for in silico drug ...